Analysts Rally Behind Waystar: Predict Robust Growth and Market Share Gains Following Competitor Setback
Analysts Rally Behind Waystar: Predict Robust Growth and Market Share Gains Following Competitor Setback
BofA Securities analyst Allen Lutz initiated coverage on Waystar Holding Corp. (NASDAQ:WAY) with a Buy rating and price forecast of $27.
美銀證券分析師艾倫·盧茨開始對Waystar Holding Corp.（納斯達克股票代碼：WAY）進行報道，買入評級，股價預測爲27美元。
According to Lutz, Waystar is well positioned for 10% revenue growth supported by steady end-market demand and recent competitive changes.
根據盧茨的說法，在穩定的終端市場需求和最近的競爭變化的支持下，Waystar完全有能力實現10％的收入增長。
In addition, the cybersecurity attack on competitor Change Healthcare could drive Waystar's market share gains.
此外，對競爭對手Change Healthcare的網絡安全攻擊可能推動Waystar的市場份額增加。
In response to the Change disruption in February, Waystar launched a program for impacted providers to expedite access to its platform within 2-3 days of contract execution.
爲了應對2月份的變革中斷，Waystar啓動了一項計劃，要求受影響的提供商在合同執行後的2-3天內加快平台的訪問速度。
The company initially added 30K provider customers and could add more over the next few quarters, the analyst adds.
分析師補充說，該公司最初增加了3萬名提供商客戶，並可能在未來幾個季度增加更多客戶。
Waystar operates in a $15 billion market, with stable ~40% margins over the next three years. Precisely, the company has a solid opportunity to expand its existing relationships with 18 of the top 22 hospitals and potential changes in the competitive environment can support further growth.
Waystar在150億美元的市場中運營，未來三年的利潤率將穩定在40％左右。確切地說，該公司有堅實的機會擴大與排名前22位的醫院中的18家的現有關係，競爭環境的潛在變化可以支持進一步的增長。
Over time, Lutz projects a structural shift in health systems, reducing dependence on Change by diversifying with independent vendors to guard against future cyber breaches. The analyst projects FY24 EPS of $0.20.
隨着時間的推移，Lutz預計衛生系統將發生結構性轉變，通過與獨立供應商進行多元化合作來減少對Change的依賴，以防未來的網絡漏洞。該分析師預計24財年每股收益爲0.20美元。
Goldman Sachs analyst Adam Hotchkiss initiated coverage on Waystar with a Buy rating and a $32 price forecast.
高盛分析師亞當·霍奇基斯開始對Waystar進行報道，評級爲買入，價格預測爲32美元。
Per Hotchkiss, Waystar's comprehensive technology platform, addressing multiple points across the healthcare revenue cycle, is unique within a market dominated by point-solution technology vendors, manual processes, and healthcare IT services businesses.
根據Hotchkiss的說法，Waystar的綜合技術平台可解決醫療收入週期中的多個問題，在由點解決方案技術供應商、手動流程和醫療保健IT服務業務主導的市場中是獨一無二的。
The analyst adds that Waystar's deliberate combination of assets drives a more compelling sale to and partnership with larger hospitals and health systems. The analyst projects FY24 EPS of $0.21.
該分析師補充說，Waystar精心整合資產推動了向大型醫院和衛生系統的更具吸引力的出售和合作。該分析師預計24財年每股收益爲0.21美元。
William Blair analyst Ryan Daniels initiates coverage on Waystar Holding with an Outperform rating.
威廉·布萊爾分析師瑞安·丹尼爾斯以跑贏大盤的評級開始對Waystar Holding進行報道。
For fiscal 2024, the analyst projects total revenue of $885 million, adjusted EBITDA of $351 million, and adjusted earnings per share of $0.19.
分析師預計，2024財年的總收入爲8.85億美元，調整後的息稅折舊攤銷前利潤爲3.51億美元，調整後的每股收益爲0.19美元。
For fiscal 2025, Daniels projects revenue of $971 million, adjusted EBITDA of $380 million, and adjusted earnings per share of $0.69.
丹尼爾斯預計，2025財年的收入爲9.71億美元，調整後的息稅折舊攤銷前利潤爲3.8億美元，調整後的每股收益爲0.69美元。
Price Action: WAY shares are trading higher by 0.46% to $21.61 at last check Tuesday.
價格走勢：週二最後一次檢查時，WAY股價上漲0.46％，至21.61美元。
Image via Dall-E 3
圖片來自 Dall-E 3